Identifying Responders to Trastuzumab Therapy in Breast Cancer Anja Brügmann; Boe S Sorensen Disclosures Future Oncol. 2011;7 (6):767-773. 0 HER2 Measurements in Blood Fractions ...

Abstract and Introduction The LifeSite Hemodialysis System (Vasca, Inc., Tewksbury, MA, USA)is totally subcutaneous, incorporating two silicone catheters positioned in the central venous system and ...

Bagsværd, Denmark, 20 June 2025 – Novo Nordisk announces subcutaneous amycretin data being presented at the American Diabetes Association (ADA) 85 th Scientific Sessions in Chicago, US.1 Full ...

Objective To compare the real-word effectiveness of subcutaneous tocilizumab (TCZ-SC) and intravenous tocilizumab (TCZ-IV) in rheumatoid arthritis (RA).Methods Patients with RA with TCZ from eight ...

Session ID: 2025-07-01:c3d96494478f7322ba15e67b Player Element ID: Vd5cd1b33_dfb7_4cb6_a47a_a289603d2ac9_6374240200112 ...

Comprehensive characterization of therapeutic monoclonal antibody (mAb) structures is critical for drug development but remains challenging due to the inherent structural heterogeneity. In this study, ...

EP: 8. Staffing and Scheduling for Subcutaneous When deciding whether to use subcutaneous (SubQ) or intravenous (IV) therapies, clinicians must weigh several clinical and practical factors.

Katie L. Kabe; Jill M. Kolesar Disclosures Am J Health Syst Pharm. 2006;63 (6):527-533.

Herceptin SC will be given to you in a hospital or clinic by a doctor or nurse. Herceptin SC is given as a subcutaneous injection (under the skin) over 2 to 5 minutes every three weeks.

This pivotal study will evaluate fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) in combination with rilvegostomig or pembrolizumab (Keytruda) as a first-line therapy for patients with ...